Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MMAF

MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A[1][2][3].

Product Specifications

CAS Number

745017-94-1

Product Name Alternative

Monomethylauristatin F

UNSPSC

12352203

Hazard Statement

H302, H315, H319, H335

Target

ADC Payload; Microtubule/Tubulin

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/mmaf.html

Purity

99.97

Solubility

DMSO : 140 mg/mL (ultrasonic)

Smiles

CC(C)[C@H](NC)C(N[C@H](C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N1CCC[C@@]1([H])[C@H](OC)[C@@H](C)C(N[C@H](C(O)=O)CC2=CC=CC=C2)=O)=O)C)=O)C(C)C)=O

Molecular Formula

C39H65N5O8

Molecular Weight

731.96

Precautions

H302, H315, H319, H335

References & Citations

[1]Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17 (1) :114-24.|[2]Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16 (9) :2562-70.|[3]Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54 (41) :12020-4.|[4]Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Isoform

Auristatin

Citation 01

J Control Release. 2018 May 10;277:48-56.|Mol Cancer Ther. 2023 Apr 3;22 (4) :459-470.|Mol Ther Nucleic Acids. 2018 Mar 2;10:227-236.|Patent. US20210393733A1.|Research Square Preprint. 2023 Dec 4.|Research Square Print. 2023 Jan 6th.|Target Oncol. 2019 Oct;14 (5) :577-590.|University of Minnesota. 2022 Sep.|Oncol Rep. 2021 Feb;45 (2) :776-785.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

NFkB p100 / p52 (NFKB2) Rabbit Polyclonal Antibody
AP02559PU-S 50 µL

NFkB p100 / p52 (NFKB2) Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
CD31 (PECAM1) Mouse Monoclonal Antibody [Clone ID: B-B38]
AM31184PU-N 2 mL (200 Tests)

CD31 (PECAM1) Mouse Monoclonal Antibody [Clone ID: B-B38]

Sign In for Pricing
View Details
Ɑ-Mercapto-ω-Amino PEG Hydrochloride
1310000-40-20.1G 1 g

Ɑ-Mercapto-ω-Amino PEG Hydrochloride

Sign In for Pricing
View Details
Alpha-Copaene (>90%)
TRC-C685210-25MG 25 mg

Alpha-Copaene (>90%)

Sign In for Pricing
View Details
3-Descyano Fludioxonil 3-Carboxylic Acid
TRC-D289771-50MG 50 mg

3-Descyano Fludioxonil 3-Carboxylic Acid

Sign In for Pricing
View Details
Oligodendrocyte Specific Protein (CLDN11) Rabbit Monoclonal Antibody
TA423553 100 µL

Oligodendrocyte Specific Protein (CLDN11) Rabbit Monoclonal Antibody

Sign In for Pricing
View Details